Novo Nordisk’s annual results are out and they ... pharmaceutical companies need to make profits on their hits because they also have a lot of misses. And hot new drugs don’t remain hot ...

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Some lawmakers even called on the FDA to probe the commercial. Novo Nordisk, maker of branded GLP-1 treatments, has now countered with an ad of its own. The ad, placed in major newspapers ...

NOW TO ANOTHER BIG STORY. WE’VE BEEN FOLLOWING THE FUTURE OF BIG LOTS. WE TOLD YOU ABOUT THE BANKRUPTCY FILING AND THE MANY STORES CLOSING FOR GOOD, THANKS TO A DEAL WITH GORDON BROTHERS AND ...